Symbol: |
TMEM189-UBE2V1
|
Description: |
TMEM189-UBE2V1 readthrough [Source:HGNC Symbol;Acc:33521]
|
Location: |
Chr20:48697661-48770174[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:121
Gene |
Compound |
Gen_sig |
Exp_pattern |
TMEM189-UBE2V1 |
Camptothecin lysinate HCl |
0.04 |
Up |
TMEM189-UBE2V1 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.013 |
Down |
TMEM189-UBE2V1 |
NSC 634398 |
0.015 |
Down |
TMEM189-UBE2V1 |
Dichlorobis[1-(4-nitrophenyl)-3-phenylpropane-1,3-dionato]-titanium(IV) |
0.028 |
Up |
TMEM189-UBE2V1 |
Tellurium, trichloro[1,2-hexanedioato(2-)-O,O']-, ammonium |
0.035 |
Down |
TMEM189-UBE2V1 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.026 |
Up |
TMEM189-UBE2V1 |
ANTINEOPLASTIC-654379 |
0.026 |
Down |
TMEM189-UBE2V1 |
1,3-dimethyl-2,4-dioxo(1H,3H)pyrimido dimethyltetrathiafulvalene |
0.019 |
Down |
TMEM189-UBE2V1 |
Nitrotolazoline |
0.003 |
Up |
TMEM189-UBE2V1 |
NSC 660809 |
0.031 |
Up |
TMEM189-UBE2V1 |
NSC 664160 |
0.028 |
Down |
TMEM189-UBE2V1 |
NSC 664217 |
0.012 |
Down |
TMEM189-UBE2V1 |
NSC 665106 |
0.032 |
Down |
TMEM189-UBE2V1 |
NSC 668578 |
0.005 |
Up |
TMEM189-UBE2V1 |
trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid |
0.028 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:47
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|